DK2001499T3 - Anvendelse af TGS-6 til behandling af osteoporose - Google Patents
Anvendelse af TGS-6 til behandling af osteoporoseInfo
- Publication number
- DK2001499T3 DK2001499T3 DK07712838.7T DK07712838T DK2001499T3 DK 2001499 T3 DK2001499 T3 DK 2001499T3 DK 07712838 T DK07712838 T DK 07712838T DK 2001499 T3 DK2001499 T3 DK 2001499T3
- Authority
- DK
- Denmark
- Prior art keywords
- tgs
- osteoporosis
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0604460.6A GB0604460D0 (en) | 2006-03-06 | 2006-03-06 | Treatment |
PCT/GB2007/000772 WO2007101988A2 (en) | 2006-03-06 | 2007-03-06 | Use of tsg-6 for treating bone diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2001499T3 true DK2001499T3 (da) | 2013-09-08 |
Family
ID=36219200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK07712838.7T DK2001499T3 (da) | 2006-03-06 | 2007-03-06 | Anvendelse af TGS-6 til behandling af osteoporose |
Country Status (7)
Country | Link |
---|---|
US (1) | US9066908B2 (da) |
EP (1) | EP2001499B1 (da) |
JP (1) | JP5346216B2 (da) |
DK (1) | DK2001499T3 (da) |
ES (1) | ES2426196T3 (da) |
GB (1) | GB0604460D0 (da) |
WO (1) | WO2007101988A2 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8609334B2 (en) | 2008-05-29 | 2013-12-17 | The Regents Of The University Of California | Biomarkers for painful intervertebral discs and methods of use thereof |
WO2015094846A2 (en) * | 2013-12-18 | 2015-06-25 | The Texas A&M University System | Treatment of gum diseases and gum disorders with tsg-6 protein |
CN111273029B (zh) * | 2020-02-25 | 2023-03-31 | 芜湖天明生物技术有限公司 | rhTSG-6双抗体夹心ELISA法定量检测试剂盒及其使用方法和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5194596A (en) * | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
EP0567575B1 (en) | 1991-01-14 | 1999-10-13 | New York University | Cytokine-induced protein, tsg-6, dna coding therefor and uses thereof |
EP0705842A2 (en) | 1994-10-06 | 1996-04-10 | Hoechst Aktiengesellschaft | Regulated genes by stimulation of chondrocytes with 1L-1beta |
WO1997004075A1 (en) | 1995-07-20 | 1997-02-06 | New York University | Pharmaceutical compositions containing tsg-6 for treating inflammatory diseases and cancer-related pathologies and methods |
EP1002132A4 (en) * | 1997-08-05 | 2005-04-27 | Human Genome Sciences Inc | HUMAN SECRETED PROTEINS |
PT1757619E (pt) | 2001-04-03 | 2010-03-25 | Nestle Sa | Osteoprotegerina no leite |
ITRM20030595A1 (it) * | 2003-12-23 | 2005-06-24 | Sigma Tau Ind Farmaceuti | Uso della ptx3 o di un suo derivato funzionale da sola o in associazione con tsg6 per il trattamento di patologie degenarative dell'osso o della cartilagine e per il trattamento della infertilita' femminile. |
-
2006
- 2006-03-06 GB GBGB0604460.6A patent/GB0604460D0/en not_active Ceased
-
2007
- 2007-03-06 JP JP2008557821A patent/JP5346216B2/ja not_active Expired - Fee Related
- 2007-03-06 EP EP07712838.7A patent/EP2001499B1/en not_active Not-in-force
- 2007-03-06 DK DK07712838.7T patent/DK2001499T3/da active
- 2007-03-06 WO PCT/GB2007/000772 patent/WO2007101988A2/en active Application Filing
- 2007-03-06 ES ES07712838T patent/ES2426196T3/es active Active
- 2007-03-06 US US12/281,920 patent/US9066908B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2007101988A2 (en) | 2007-09-13 |
JP5346216B2 (ja) | 2013-11-20 |
EP2001499A2 (en) | 2008-12-17 |
ES2426196T3 (es) | 2013-10-21 |
JP2009532334A (ja) | 2009-09-10 |
US9066908B2 (en) | 2015-06-30 |
US20090099084A1 (en) | 2009-04-16 |
WO2007101988A3 (en) | 2007-11-01 |
EP2001499B1 (en) | 2013-06-05 |
GB0604460D0 (en) | 2006-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2137537T3 (da) | Sammensætninger og anvendelser til behandling af multipel sklerose | |
ATE477312T1 (de) | Flüssigkeitshärtung | |
DK2061561T3 (da) | Sammensætninger til behandling af cancer | |
DK1685834T3 (da) | Anvendelse af pinolensyre til behandling af obesitet | |
BRPI0813546A2 (pt) | interface ortopédica | |
ES1063346Y (es) | Andador | |
DK3403657T3 (da) | Anvendelse af oligouronater til behandling af slimhyperviskositet | |
DK2079485T3 (da) | Phenylpropionamidforbindelser og anvendelsen deraf | |
DK2101805T3 (da) | Integrinligander til anvendelse i behandling af cancer | |
DK2235002T3 (da) | 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer | |
DK2200600T3 (da) | Neramexan til anvendelse ved behandlingen af subakut tinnitus | |
DE602007000495D1 (de) | Flüssigkeit-Koinfusionsgerät | |
DK2173831T3 (da) | Brøndbehandling | |
DK2004183T3 (da) | Mazindol-kombination i behandlingen af opmærksomhedsunderskud/hyperaktivitet | |
BRPI0813116A2 (pt) | Tornozeleira e kit de tornozeleira | |
DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme | |
DE602007003905D1 (de) | Verbinder | |
DK2215314T3 (da) | Indretning til behandling af regnvand | |
BRPI0816288A2 (pt) | Processos e compostos | |
DE602007001119D1 (de) | Verbinder | |
BRPI0817439A2 (pt) | gaseificador | |
DK2001499T3 (da) | Anvendelse af TGS-6 til behandling af osteoporose | |
DK2107906T3 (da) | Hidtil ukendt terapeutisk anvendelse til behandling af leukæmier | |
BRPI0719997A2 (pt) | Uso de epotilonas no tratamento de osteoporose e doenças relacionadas | |
DE102007047112A8 (de) | Strahlregler |